Article
Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling.
Nature cell biology - 1 Sept 2002
Gao Xinsheng, Zhang Yong, Arrazola Peter, Hino Okio, Kobayashi Toshiyuki, Yeung Raymond S, Ru Binggeng, Pan Duojia
Abstract excerpt
Target of Rapamycin (TOR) mediates a signalling pathway that couples amino acid availability to S6 kinase (S6K) activation, translational initiation and cell growth. Here, we show that tuberous sclerosis 1 (Tsc1) and Tsc2, tumour suppressors that are responsible for the tuberous sclerosis syndrome, antagonize this amino acid-TOR signalling pathway. We show that Tsc1 and Tsc2 can physically associate with TOR and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
